 BrainsWay Ltd. NASDAQ TASE: BWAY BrainsWay today announced final positive results from its pivotal multicenter trial assessing the safety and efficacy of the Companys H4 Deep transcranial magnetic stimulation system Deep TMS as an aid in smoking cessation in adults suffering from chronic smoking addiction. This trial represents the first multicenter pivotal study conducted with any non-invasive brain stimulation device in the addiction space. 